Company News

SkinMedica, Mass General Hospital Announce Accord

Will screen 40K natural extracts for applications in pigmentation.

Author Image

By: TOM BRANNA

Editor

SkinMedica will collaborate with Massachusetts General Hospital (MGH) for the research and development of pigmentation products, the Carlsbad, CA company announced. The exclusive agreement invovlves screening and evaluating a library of roughly 40,000 natural extracts made available by the National Cancer Institute for potential applications in pigmentation. The principal investigator for this collaborative effort is David Fisher, M.D., Ph.D., chief of the Massachusetts General Hospital Dep...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters